ARTICLE | Clinical News
Qbrelis lisinopril oral solution regulatory update
August 15, 2016 7:00 AM UTC
FDA approved Qbrelis lisinopril oral solution from Silvergate for the treatment of hypertension in patients ages >=6 and for acute myocardial infarction (MI) in adults and as adjunctive therapy of hea...